| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
China Resources Double-Crane Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.94 |
| 52 Week High | CN¥26.15 |
| 52 Week Low | CN¥14.80 |
| Beta | 0.14 |
| 11 Month Change | 10.87% |
| 3 Month Change | 28.66% |
| 1 Year Change | 52.32% |
| 33 Year Change | 95.23% |
| 5 Year Change | 80.49% |
| Change since IPO | 705.84% |
Recent News & Updates
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Low P/E No Reason For Excitement
Oct 21
An Intrinsic Calculation For China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Suggests It's 49% Undervalued
Sep 30We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease
Jul 16Recent updates
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Low P/E No Reason For Excitement
Oct 21An Intrinsic Calculation For China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Suggests It's 49% Undervalued
Sep 30We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease
Jul 16China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 24Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel
Mar 02Shareholder Returns
| 600062 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.2% | 1.6% | 2.7% |
| 1Y | 52.3% | 0.7% | 4.6% |
Return vs Industry: 600062 exceeded the CN Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 600062 exceeded the CN Market which returned 4.6% over the past year.
Price Volatility
| 600062 volatility | |
|---|---|
| 600062 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 7.6% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 600062 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600062's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1939 | 12,269 | Wenchao Lu | www.dcpc.com |
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other.
China Resources Double-Crane Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600062 fundamental statistics | |
|---|---|
| Market cap | CN¥23.56b |
| Earnings (TTM) | CN¥1.39b |
| Revenue (TTM) | CN¥10.31b |
16.9x
P/E Ratio2.3x
P/S RatioIs 600062 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600062 income statement (TTM) | |
|---|---|
| Revenue | CN¥10.31b |
| Cost of Revenue | CN¥4.60b |
| Gross Profit | CN¥5.71b |
| Other Expenses | CN¥4.32b |
| Earnings | CN¥1.39b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 26, 2024
| Earnings per share (EPS) | 1.36 |
| Gross Margin | 55.40% |
| Net Profit Margin | 13.53% |
| Debt/Equity Ratio | 2.0% |
How did 600062 perform over the long term?
See historical performance and comparison